Gensight Biologics (SIGHT.PA) traded down -4.5 % during a 24 hours period ending at 04:13 PM Central Europe on Monday 26th. One Gensight Biologics stock can currently be bought for about EUR 0.07 on popular exchanges. Current supply of Gensight Biologics stocks is 245.3 mn. Gensight Biologics has a current market capitalization of EUR 17.2 mn and approximately EUR 42.8 k worth of Gensight Biologics was traded on exchanges in the last 24 hours. Since last month end, Gensight Biologics has traded -46.89 % down. Simple moving average of last 200 days is at EUR 0.09. The highest price of past 52 weeks was recorded at EUR 0.24 on 10/30/2025. 52 weeks low was at EUR 0.07 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Mon Courtier Energie Groupe (ALMCE.PA) traded down -0.92 % and now trades at EUR 5.35. Current market capitalisation for Mon Courtier Energie Groupe is EUR 19.1 mn.
Genoway (ALGEN.PA) traded flat 0 % and now trades at EUR 2.19. Current market capitalisation for Genoway is EUR 20.3 mn.
Valbiotis (ALVAL.PA) traded up 0.36 % and now trades at EUR 0.57. Valbiotis has a market capitalisation of EUR 19.7 mn.
U (ALU10.PA) traded down -6.67 % and now trades at EUR 1.13. U has a market capitalisation of EUR 19.1 mn. Current price/earnings ratio for U is 14.
Maat Pharma Saca (MAAT.PA) traded up 0.56 % and now trades at EUR 1.06. Maat Pharma Saca has a market capitalisation of EUR 20.1 mn.
About Gensight Biologics
GenSight Biologics SA is a clinical-stage biotechnology company that specializes in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative eye and central nervous system diseases.